Cytokine Status Disorders and Their Role in the Pathogenesis of Chronic Abacterial Prostatitis of Non-Inflammatory Nature

Relevance. Chronic abacterial prostatitis (CAP) of a non-inflammatory nature remains a complex disease in terms of proven etiological factors and pathogenetic mechanisms. Recent studies define it as a nosology based on homeostasis disorders with damaging effects directed towards the prostate. Pathogenetically, this is cytokine aseptic inflammation and lipid peroxidation, which occurs under conditions of compromised antioxidant protection. Objective — to study the cytokine status in the experimental reproduction of non-inflammatory CAP models.
Materials and methods. 100 male white rats were studied, 25 formed a control group, and the remaining ones were divided into 3 equal groups for experiments on creating various models of CAP and systemic chronic stress. At the end of the experiment, blood was taken and the prostate was removed to obtain a homogenate. The substrates were used to determine pro- and anti-inflammatory cytokines.
Results. In the isolated CAP model of category IIIB, cytokine disorders were detected in prostate tissue (to a greater extent), and at the systemic level (to a lesser extent). The model of systemic immobilization stress proved the possibility of triggering cytokine disorders in prostate tissue characteristic of CAP IIIB. Severe homeostasis disorders at the systemic and local levels were observed in experiments where both systemic stress and the local CAP model were modeled.
Conclusion. Cytokine imbalance plays a key role in the pathogenesis of СAP IIIB. At the same time, systemic and organ cytokine disorders interact with each other and, under certain circumstances, aggravate the damaging effect of each other.

1. Kulchavenya EV, Shevchenko SYu, Cherednichenko AG. New possibilities of application of hyaluronidase in chronic prostatitis. Urologiia. 2020;(3):56–62. (In Russ.). DOI: https://doi.org/10.18565/urology.2020.3.56–62.

2. Tyuzikov IA. Interrelation of systemic factors in the pathogenesis of chronic pelvic pain syndrome in men. Urologiia. 2012;(6):48–51. (In Russ.). EDN: https://elibrary.ru/pivkel.

3. Nickel JC. Chronic prostatitis/chronic pelvic pain syndrome: It is time to change our management and research strategy. BJU International. 2020;125(4):479–480. DOI: https://doi.org/10.1111/bju.15036.

4. Strotsky AV. Chronic prostatitis: A “new” approach to an old problem? Meditsinskie novosti. 2006;(8):19–22. (In Russ.). Available from: https://clck.ru/3CVkBT [accessed 10 January 2024].

5. Alyaev YuG, Vinarov AZ, Pshikhachev AM, Varshavsky VA, Stoilov SV. Chronic abacterial prostatitis: Do we know everything? Andrology and Genital Surgery. 2010;11(3):90–94. (In Russ.). EDN: https://elibrary.ru/mwgpft.

6. Sivkov AV, Romikh VV, Zakharchenko AV. Category IIIB chronic prostatitis/chronic pelvic pain syndrome and sexual dysfunction. Andrology and Genital Surgery. 2015;16(4):18–26. (In Russ.). EDN: https://elibrary.ru/vkpnqj.

7. Cohen JM, Fagin AP, Hariton E, Niska JR, Pierce MW, Kuriyama A, et al. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A systematic review and meta-analysis. PLoS One. 2012;7(8):e41941. DOI: https://doi.org/10.1371/journal.pone.0041941.

8. Alyaev YuG, Rapoport LM, Tsarichenko DG, Demidko LJ. Diagnosis and treatment of prostate diseases. Effective Pharmacotherapy. 2011;(41):36–38. (In Russ.). EDN: https://elibrary.ru/sgidgn.

9. Tyuzikov IA. Chronic pelvic pain in men: Optimization of pathogenetic pharmacotherapy from the standpoint of an interdisciplinary approach. RMJ. 2016;24(23):1535–1541. (In Russ.). EDN: https://elibrary.ru/xrmamp.

10. Tyuzikov IA, Ivanov AP. Abacterial syndrome of chronic pelvic pain in men as a multidisciplinary problem. Fundamental Research. 2012;(1):121–124. (In Russ.). EDN: https://elibrary.ru/pazaut.

11. Tyuzikov IA. Interrelation of systemic factors in the pathogenesis of chronic pelvic pain syndrome in men. Urologiia. 2012;(6):48–51. (In Russ.). EDN: https://elibrary.ru/pivkel.

12. Dolgov AB, Popkov VM, Churakov AA. Chronic abacterial pro-statitis/chronic pelvic pain syndrome: A modern view on the aspects of pathogenesis. Modern Problems of Science and Education. 2016;(4):62. (In Russ.). EDN: https://elibrary.ru/wiqbvl.

13. Curtis Nickel J, Baranowski AP, Pontari M, Berger RE, Tripp DA. Management of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome who have failed traditional management. Reviews in Urology. 2007;9(2):63–72. PMID: https://pubmed.gov/17592539.

14. Kulchavenya EV, Kholtobin DP, Shevchenko SYu, Potapov VV, Zulin VV. The frequency of chronic prostatitis in the structure of outpatient urological care. Experimental and Clinical Urology. 2015;(1):16–19. (In Russ.). EDN: https://elibrary.ru/udfiwv.

15. Konoplya AI, Shatokhin MN, Gavrilyuk VP. Immunological problems of chronic prostatitis. Immunopathology, Allergology, Infectology. 2015;(2):29–34. (In Russ.). EDN: https://elibrary.ru/vaoebj.

16. Breser ML, Salazar FC, Rivero VE, Motrich RD. Immunological mechanisms underlyng chronic pelvic pain and prostate inflammation in chronic pelvic pain syndrome. Frontiers in Immunology. 2017;8:898. DOI: https://doi.org/10.3389/fimmu.2017.00898.

17. Carmeli E, Coleman R, Reznick AZ. The biochemistry of aging muscle. Experimental Gerontology. 2002;37(4):477–489. DOI: https://doi.org/10.1016/s0531-5565(01)00220-0.

18. Dorofeev SD, Kudryavtsev YuV, Kudryavtseva LV. Immunohistochemical aspects of chronic abacterial prostatitis. Effective Pharmacotherapy. 2014;(2):26–38. (In Russ.). EDN: https://elibrary.ru/rwhiov.

19. Jang TL, Schaeffer AJ. The role of cytokines in prostatitis. World Journal of Urology. 2003;21(2):95–99. DOI: https://doi.org/10.1007/s00345-003-0335-2.

20. Aleshin BV, Bondarenko LA, Breslavskii AS, Vartapetov BA, Gladkova AI. Functional and structural changes in the adrenal cortex of rabbits with chronic prostatitis. Bulletin of Experimental Biology and Medicine. 1977;83(3):308–309. DOI: https://doi.org/10.1007/BF00799345.

21. McClinton S, Eremin O, Miller ID. Inflammatory infiltrate in prostatic hypherplasia — Evidence of a host response to intraprostatic spermatozoa? BJU International. 1990;65(6):606–610. DOI: https://doi.org/10.1111/j.1464-410x.1990.tb14828.x.

22. Kovalchuk LV, Gankovskaya LV, Nikankina LV, Dolgina EN, Shcheglovitova ON. From autolymphokinotherapy to the controlled preparation of the cytokine complex Superlimf. Allergy, Asthma and Clinical Immunology. 2001;(6):28–33. (In Russ.).

23. Kramer G, Marberger M. Could inflammation be a key component in the progression of benign prostatic hyperplasia? Current Opinion in Urology. 2006;16(1):25–29. DOI: https://doi.org/10.1097/01.mou.0000193368.91823.1b.

24. Tsvetkov IS, Makarova OV, Mkhitarov VA. Experimental models of chronic prostatitis. Clinical and Experimental Morphology. 2013;(1):60–65. (In Russ.). EDN: https://elibrary.ru/pxwmvv.

25. Bostwick DG, De la Roza G, Dundore P, Corica FA, Iczkowski KA. Intraepithelial and stromal lymphocytes in the normal human prostate. The Prostate. 2003;55(3):187–193. DOI: https://doi.org/10.1002/pros.10224.

26. Hua VN, Schaeffer AJ. Acute and chronic prostatitis. Medical Clinics of North America. 2004;8(28):483–494. DOI: https://doi.org/10.1016/s0025-7125-(03)00169‑x.

27. Shoskes DA, Albakri Q, Thomas K, Cook D. Cytokine polymorphisms in men with chronic prostatitis/ chronic pelvic pain syndrome: Association with diagnosis and treatment response. Journal of Urology. 2002;168(1):331–335. DOI: https://doi.org/10.1016/S0022-5347(05)64916-6.

28. Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 1998;5(52):744–749. DOI: https://doi.org/10.1016/s0090-4295(98)00390-2.

29. Duan ZG, Yang WM. Analysis of cytokines (IL‑2, IL‑8, IL‑10) in the expressed prostatic secretions of chronic prostatitis. Zhonghua Nan Ke Xue. 2005;11(3):201–203. (In Chin.). PMID: https://pubmed.gov/15804113.

30. Sadretdinov RA, Polunin AA, Asfandiyarov FR. Analysis of the level of interleukin‑8 in chronic prostatitis. International Journal of Experimental Education. 2015;(3–1):69–70. (In Russ.). EDN: https://elibrary.ru/tjdkhl.

31. Konoplya AI, Teodorovich OV, Shatokhin MN, Gavrilyuk VP, Mavrin MY. Chronic prostatitis, prostate adenoma and immunity: Disorders and correction. Urologiia. 2013;(4):99–103. (In Russ.). EDN: https://elibrary.ru/rioiwf.

32. Neymark BA, Neymark AI, Davydov AV, Klepikova II, Nozdrachev NA, Razdorskaya MV. The role of cytomedines in the treatment of patients with chronic prostatitis accompanied by disorders of spermatogenesis. Urologiia. 2015;(5):70–73. (In Russ.). DOI: https://elibrary.ru/uymtrh.

33. Razumov SV, Medvedev AA, Chirun NV, Sivkov AV, Oschepkov VN, Sinyukhin VN. The role of cytokines in the diapastics of chronic prostatitis. Urologiia. 2003; (6):25–28. (In Russ.). EDN: https://elibrary.ru/myzpwk.

34. Totolyan AA, Al-Shukri SH, Kozlov VV. Diagnostic significance of the determination of interleukin‑8 in chronic prostatitis. Urologiia. 2001;(6):6–8.

35. Shatokhin MI, Teodorovich OV, Konoplya AI, Gavrilyuk VP, Mavrin MYu, Krasnov AV. Immunometabolic disorders in chronic bacterial prostatitis and their correction. Urologiia. 2011;(5):39–42. EDN: https://elibrary.ru/oklgvr.